|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/755 | |
| A61K 38/37 |
| (11) | Patento numeris | 2536753 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11701527.1 |
| Europos patento paraiškos padavimo data | 2011-02-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-12-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-12-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/051438 |
| Data | 2011-02-02 |
| (87) | Numeris | WO 2011/101242 |
| Data | 2011-08-25 |
| (30) | Numeris | Data | Šalis |
| 305608 P | 2010-02-18 | US | |
| 10153718 | 2010-02-16 | EP |
| (72) |
PESCHKE, Bernd, DK
KOFOD-HANSEN, Mikael, DK
BUCHARDT, Jens, DK
STENNICKE, Henning Ralf, DK
STERGAARD, Henrik, DK
KJALKE, Marianne, DK
OLSEN, Eva H. Norling, DK
HANSEN, Jens Jacob, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | FACTOR VIII MOLECULES WITH REDUCED VWF BINDING |
| FACTOR VIII MOLECULES WITH REDUCED VWF BINDING |